Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: A multicenter observational study of 300 dogs
Open Access
- 21 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 35 (6) , 2853-2864
Abstract
Background: Radiation therapy is commonly used as an adjunct to incomplete surgical excision in dogs with mast cell tumors (MCT), but the optimal dose and fractionation regimen have yet to be determined. Hypothesis: We assessed outcomes (time to local recurrence, patient survival and toxicity) of a large population of dogs with MCT that received adjunctive radiation therapy. Animals: Three hundred dogs with 302 MCT treated using adjunctive radiation therapy. Methods: Retrospective observational study. Clinical records of 4 veterinary radiation centers were reviewed. Results: Local recurrence rates were similar regardless of radiation protocol with 6.6% of patients developing recurrent cutaneous MCT at a median of 526 days. Local recurrence rate was similar between high and low-risk MCT. Mast cell tumor related death was reported in 19% of all dogs, with 13% of dogs with low-risk MCT dying of their disease compared to 29% of dogs with high-risk MCT. No SC MCT (SCMCT) recurred after radiation therapy and only 7% of dogs with SCMCT were reported to have died of their disease. Mild late toxicity was common in both protocols and severe late toxicity occurred in 1.9% of dogs many years after treatment. Conclusions and Clinical Importance: Our study supports the use of adjunctive radiation for the long-term control of incompletely or narrowly excised cutaneous and SCMCT in dogs. More moderate dose and fractionation protocols may be appropriate in the adjunctive treatment of low-risk MCT in dogs. Large multicenter prospective studies are required to establish the optimal dose and fractionation for MCT of different risk categories.Keywords
This publication has 47 references indexed in Scilit:
- Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumoursVeterinary and Comparative Oncology, 2013
- COMPLETENESS OF REPORTING OF RADIATION THERAPY PLANNING, DOSE, AND DELIVERY IN VETERINARY RADIATION ONCOLOGY MANUSCRIPTS FROM 2005 TO 2010Veterinary Radiology & Ultrasound, 2011
- Canine Subcutaneous Mast Cell TumorsVeterinary Pathology, 2010
- Canine Subcutaneous Mast Cell TumorVeterinary Pathology, 2010
- Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological BehaviorVeterinary Pathology, 2010
- Association of Ki67 index with prognosis for intermediate‐grade canine cutaneous mast cell tumours*Veterinary and Comparative Oncology, 2008
- Canine Mast Cell Tumors: Correlation of Apoptosis and Proliferation Markers with PrognosisJournal of Veterinary Internal Medicine, 2006
- Canine Mast Cell Tumors: Correlation of Apoptosis and Proliferation Markers with PrognosisJournal of Veterinary Internal Medicine, 2006
- A Prospective Study of Radiation Therapy for the Treatment of Grade 2 Mast Cell Tumors in 32 DogsJournal of Veterinary Internal Medicine, 1996
- The linear-quadratic formula and progress in fractionated radiotherapyBritish Journal of Radiology, 1989